Overexpression of miR-26b decreases the cisplatin-resistance in laryngeal cancer by targeting ATF2

Cisplatin is a common used chemotherapeutic drug for the treatment of laryngeal cancer. However, drug-resistance is a major obstacle in platinum-based chemotherapy for laryngeal cancer. Recent studies have demonstrated that dysregulation of microRNAs (miRNAs) is responsible for chemoresistance in mu...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Linli, Zhang, Jiarui, Ren, Xiuxia, Liu, Xinyu, Gao, Wei, Zhang, Chen, Sun, Yanan, Liu, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668017/
https://www.ncbi.nlm.nih.gov/pubmed/29108284
http://dx.doi.org/10.18632/oncotarget.20784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668017/
https://www.ncbi.nlm.nih.gov/pubmed/29108284
http://dx.doi.org/10.18632/oncotarget.20784

Ejemplares similares